Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5226841 | 0.81 | ESR1 (0.58) | ESR1S1PR1MAPTRAB9AC5AR1 | |
| SCHEMBL3164442 | 0.79 | ESR1 (0.64) | ESR1S1PR1MAPTRAB9AC5AR1 | |
| SCHEMBL6063203 | 0.76 | ESR1 (0.79) | ESR1S1PR1MAPTRAB9AC5AR1 | |
| SCHEMBL28722339 | 0.70 | C5AR1 (0.76) | ESR1S1PR1RAB9AC5AR1LMNA | |
| SCHEMBL8087654 | 0.68 | ESR1 (0.74) | ESR1S1PR1RAB9AC5AR1LMNA | |
| SCHEMBL39946 | 0.67 | ESR1 (0.44) | ESR1S1PR1MAPTLMNASMN1; SMN2 | |
| SCHEMBL9818045 | 0.67 | ESR1 (0.44) | ESR1S1PR1MAPTLMNASMN1; SMN2 | |
| Benzene SCHEMBL27985319 | 0.67 | ESR1 (0.44) | ESR1S1PR1MAPTLMNASMN1; SMN2 | |
| SCHEMBL1678584 | 0.67 | ESR1 (0.65) | ESR1S1PR1MAPTRAB9AC5AR1 | |
| SCHEMBL9258205 | 0.67 | ESR1 (0.89) | ESR1S1PR1MAPTRAB9AC5AR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1994018161-A1 | SUBSTITUTED PHENYL SULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY | MERCK & CO., INC. (US) | 1994-08-18 | — | — | WO | disclosed |